ストックスクリーナーアプリを入手
3.65
7.59%
-0.30
アフターアワーズ：
3.65
Alto Neuroscience Inc (ANRO) 最新ニュース
Schizophrenia Drugs Market reached US$ 10.03 billion in 2024 - openPR
Alto Neuroscience, Inc. (NYSE:ANRO) Receives $20.00 Average Price Target from Analysts - MarketBeat
Alto Neuroscience announces $75 million ATM offering - MSN
Alto Neuroscience Files For Mixed Shelf Of Up To $300 Million -February 03, 2025 at 05:06 pm EST - Marketscreener.com
Alto Neuroscience announces $75 million ATM offering By Investing.com - Investing.com UK
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Precision neuropsychiatry spotlight: a BioCentury podcast - BioCentury
JPMorgan Chase & Co. Acquires 20,536 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Alto Neuroscience, Inc. (ANRO) And Encourages Stockholders to Reach Out - ACCESS Newswire
Barclays PLC Raises Stock Position in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Jane Street Group LLC Takes $124,000 Position in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
All You Need to Know About Alto Neuroscience, Inc. (ANRO) Rating Upgrade to Buy - Yahoo Finance
Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Stock Holdings Increased by Geode Capital Management LLC - Defense World
Alto Neuroscience, Inc. (NYSE:ANRO) Shares Bought by Geode Capital Management LLC - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Shares Acquired by Barclays PLC - Defense World
Alto Neuroscience, Inc. (NYSE:ANRO) Stake Raised by Geode Capital Management LLC - ETF Daily News
State Street Corp Grows Position in Alto Neuroscience, Inc. (NYSE:ANRO) - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Shares Purchased by State Street Corp - Defense World
Alto Neuroscience Presents Key Data, Study Findings on ALTO-300 - Psychiatric Times
For precision psychiatry, 2024 was one step forward, two steps back - BioWorld Online
Franklin Resources Inc. Buys 595,673 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Position Boosted by BNP Paribas Financial Markets - Defense World
Charles Schwab Investment Management Inc. Acquires 120,779 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Jones Trading sets Alto Neuroscience shares at Buy on portfolio By Investing.com - Investing.com Canada
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Alto Neuroscience, Inc. (NYSE:ANRO) Sees Significant Drop in Short Interest - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Shares Bought by The Manufacturers Life Insurance Company - Defense World
Alto Neuroscience, Inc. (NYSE:ANRO) Receives $20.00 Average PT from Analysts - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology - BioSpace
Alto Neuroscience Unveils Breakthrough Precision Psychiatry Data at Major Neuroscience Conference - StockTitan
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm - The Eastern Progress Online
ANRO Investors Have Opportunity to Join Alto Neuroscience, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
Fmr LLC Boosts Stake in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World
Jennison Associates LLC Buys 370,612 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - MarketBeat
Alto Neuroscience (NYSE:ANRO) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
What is William Blair's Forecast for ANRO FY2024 Earnings? - MarketBeat
Wedbush Equities Analysts Reduce Earnings Estimates for ANRO - MarketBeat
RA Capital Management Reduces Stake in Alto Neuroscience Inc - GuruFocus.com
Stifel Nicolaus Has Lowered Expectations for Alto Neuroscience (NYSE:ANRO) Stock Price - MarketBeat
FMR LLC Acquires Shares in Alto Neuroscience Inc - GuruFocus.com
Alto Neuroscience Reports $182M Cash Position Despite Widening Losses in Q3 | ANRO Stock News - StockTitan
Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance
Latest Company News - Investing.com
Largest borrow rate increases among liquid names - TipRanks
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC - GlobeNewswire
Alto Neuroscience to Participate in Upcoming Investor Conferences - StockTitan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alto Neuroscience, Inc. (ANRO) And Encourages Stockholders to Connect - AccessWire
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Learn More About the Investigation - AccessWire
Alto Neuroscience, Inc. (ANRO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Alto Neuroscience, Linkage Global, Pixie Dust: Top 3 Stocks With Explosive Retail Follower Growth Last Week - Barchart
1.03%
大文字化:
|
ボリューム (24 時間):